«Back

Class 2 Recall on Zantac GSK

Class 2 Recall on Zantac GSK

GlaxoSmithKline is recalling all unexpired stock of Zantac (ranitidine hydrochloride) prescription only medicines (POM) from pharmacies as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code Product Description Supplier Affected Batch
453720 ZANTAC INJECTION 50MG/2ML GLAXOSMITHKLINE UK LTD ALL STOCK
413229 ZANTAC SYR GLAXOSMITHKLINE UK LTD ALL STOCK
221911 ZANTAC TAB 150MG GLAXOSMITHKLINE UK LTD ALL STOCK
317685 ZANTAC TAB 300MG GLAXOSMITHKLINE UK LTD ALL STOCK

For stock control enquiries please refer to https://gskpro.com/en-gb/ or contact 0800-221-441.

For medical information enquiries please contact ukmedinfo@gsk.com, via the Live Chat facility on https://hcp.gsk.co.uk/contact-us/live-chat.html or on 0800 221 441 (option 2).

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.